Recommendations for laboratory testing of <scp>UK</scp> patients with acute myeloid leukaemia-Reference-Cited by-同舟云学术

Recommendations for laboratory testing of UK patients with acute myeloid leukaemia

Published:2022-10-24 Issue:2 Volume:200 Page:150-159
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mehta Priyanka¹^ORCID,Telford Nick²,Wragg Chris³,Dillon Richard⁴^ORCID,Freeman Sylvie⁵^ORCID,Finnegan Damian⁶,Hamblin Angela⁷,Copland Mhairi⁸^ORCID,Knapper Steve⁹

Affiliation:

1. University Hospitals of Bristol and Weston NHS FoundationTrust Bristol UK

2. Oncology Cytogenetics The Christie NHS Foundation Trust Manchester UK

3. Bristol Genetic Laboratory North Bristol NHS Trust Westbury on Trym UK

4. Cancer Genetics Laboratory Department of Medical and Molecular Genetics, King's College London UK

5. Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK

6. Department of Haematology Belfast City Hospital Belfast UK

7. NIHR Oxford Biomedical Research Centre Oxford University Hospitals NHS Foundation Trust & Genomics Oxford UK

8. Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences University of Glasgow Glasgow UK

9. Department of Haematology, School of Medicine Cardiff University Cardiff UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18516

Reference32 articles.

1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

2. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

3. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

4. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

5. Current status and new treatment approaches in TP53 mutated AML

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study;Pathology;2024-06

2. Association of genetic predisposition studies in CYP1A1 polymorphism studies in acute myeloid leukemia;Saudi Journal of Biological Sciences;2024-03

3. AML in the elderly—A global view;British Journal of Haematology;2023-10-11

4. Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting;Blood Advances;2023-08-28

5. Correction to “Recommendations for laboratory testing of UK patients with acute myeloid leukaemia”;British Journal of Haematology;2023-03-14